{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Batabulin_Sodium",
  "nciThesaurus": {
    "casRegistry": "195533-98-3",
    "chebiId": "",
    "chemicalFormula": "C13H6F6NO3S.Na",
    "definition": "The sodium salt form of batabulin, a synthetic pentafluorophenylsulfonamide with potential antineoplastic activity. Batabulin covalently binds to and selectively modifies the beta 1, beta 2, beta 3, and beta 4 isotypes of beta tubulin at a conserved cysteine residue, resulting in disruption of microtubule polymerization, collapse of the cytoskeleton, an increase in chromosomal ploidy, cell cycle arrest, and tumor cell apoptosis.",
    "fdaUniiCode": "G04B77F772",
    "identifier": "C1835",
    "preferredName": "Batabulin Sodium",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C67421"
    ],
    "synonyms": [
      "2-Fluoro-1-methoxy-4-(pentafluorophenyl-sulfonamido)benzene, Sodium Salt",
      "BATABULIN SODIUM",
      "Batabulin Sodium",
      "T138067 Sodium"
    ]
  }
}